Exploration of the association between SF3B4 and HMGB1 expression and the clinicopathological features and prognosis of gastric cancer

Table 7 Multivariate logistic regression analysis of risk factors for 1-year mortality in gastric cancer patients with poor prognosis

Factor	β	SE	Wald	P value	Odds ratio	95% confidence interval
SF3B4 ≥ 1.45	1.443	0.155	6.456	< 0.001	4.221	1.037-4.625
HMGB1 ≥ 0.93	1.352	0.103	5.794	< 0.001	3.875	1.143-6.192
Poor tumor differentiation	0.819	0.091	6.012	< 0.001	2.264	1.269-5.732
Maximum tumor diameter, ≥ 5 cm	0.914	0.075	5.568	< 0.001	2.493	1.335-7.519
Tumor invasion depth, T3-T4	0.742	0.061	5.937	< 0.001	2.089	1.026-5.368
Lymph node metastasis	1.025	0.094	6.027	< 0.001	2.783	1.165-4.594
cTNM stage III-IV	1.109	0.086	5.685	< 0.001	3.017	1.418-5.798

SF3B4: Splicing factor 3b subunit 4; HMGB1: High mobility group box 1; cTNM: Clinical tumor-node-metastasis.